Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Morphic Holding Inc (MORF)

Morphic Holding Inc (MORF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Morphic Holding Inc 35 Gatehouse Drive A2 Waltham MA 02451 USA

www.morphictx.com P: 781-996-0955

Description:

Morphic Holding Inc. is a biopharmaceutical company. It focuses on the discovery and development of oral small-molecule integrin therapeutics for autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. Morphic Holding Inc. is based in Waltham, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 2,854,857
Enterprise Value, $K 2,796,277
Shares Outstanding, K 50,094
Annual Sales, $ 520 K
Annual Net Income, $ -152,100 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -57,590 K
EBIT, $ -213,010 K
EBITDA, $ -222,510 K
60-Month Beta 1.49
% of Insider Shareholders 25.60%
% of Institutional Shareholders 94.25%
Float, K 37,270
% Float 74.40%
Short Volume Ratio 0.50

Growth:

1-Year Return 6.72%
3-Year Return -0.44%
5-Year Return 171.25%
5-Year Revenue Growth -84.52%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.15 on 07/25/24
Next Earnings Date 08/01/24
Earnings Per Share ttm -3.73
EPS Growth vs. Prev Qtr -26.37%
EPS Growth vs. Prev Year -25.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MORF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.62%
Return-on-Assets % -25.74%
Profit Margin % -29,250.00%
Debt/Equity 0.00
Price/Sales 5,491.97
Price/Cash Flow N/A
Price/Book 4.63
Book Value/Share 12.31
Interest Coverage -2.91
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar